Sources on the risks of thrombosis

Patients are usually warned about the risks of thrombosis - deep vein thrombosis and thromboembolic events. This pages gives a number of articles whose conclusions show a few things:

  • Risks depends on the administration routes: transdermal and injections are safer than oral
  • Risks depends on the type of estrogens: synthetic and non-bioidentical should be avoided

Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review

Pharmacology of estrogens and progestogens: influence of different routes of administration

Menopausal hormone therapy and venous thromboembolism

Oral Contraceptives and HRT Risk of Thrombosis

Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases

Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases

Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.

Therapy Insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy


Last modified December 14, 2023: sourcesaddon (88b238a)